Subscribe to our News Updates & Alerts
ASX AGN:
A$
Home
About
Company Overview
Our Mission
Board & Management
Clinical Advisory Committee
Partnerships
Investors
Share Information
Announcements & Reports
ASX Announcements
Corporate Directory
Corporate Governance
Technology
The Science
Development
Publications
Media
News & Media
Contact
2021
2022
28 Oct 2021
Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer’s Disease.
Reference:
Mamsa SSA, Meloni BP. Front Mol Neurosci. 2021 Oct 28;14:759729. doi: 10.3389/fnmol.2021.759729. eCollection 2021. PMID: 34776866 Free PMC article. Review.
18 Oct 2021
Can this biotech tap into a $183 billion market by buying time for stroke patients?
Reference:
The Sentiment
18 Oct 2021
Argenica Therapeutics to start phase 1 clinical trials early next year
Reference:
Small Caps
03 Nov 2021
Argenica Therapeutics reveals positive pre-clinical results of stroke drug ARG-007 in HIE
Reference:
Smalls Caps
31 Dec 2021
IPO Watch: ASX IPOs in 2021 were up 14 per cent on average; here are the best performers
Reference:
Stockhead
30 Dec 2021
Here’s Why We’re Not Too Worried About Argenica Therapeutics’ (ASX:AGN) Cash Burn Situation
Reference:
Simply Wall Street
24 Jan 2022
Argenica Therapeutics completes pre-clinical toxicology studies of stroke drug
Reference:
Small Caps
13 Jan 2022
Argenica Therapeutics secures experienced professional to lead clinical development of stroke drug
Reference:
Small Caps
24 Feb 2022
Argenica Therapeutics moves closer to clinical trials after completing genotoxicity studies on ARG-007
Reference:
Small Caps
21 Mar 2022
Argenica Therapeutics publishes scientific paper on ARG-007 ahead of clinical trials
Reference:
Small Caps
Subscribe to our mailing list to stay up to date with Argenica Therapeutics
First Name
*
Last Name
*
Email
*
Home
About
Company Overview
Our Mission
Board & Management
Clinical Advisory Committee
Partnerships
Investors
Share Information
Announcements & Reports
ASX Announcements
Corporate Directory
Corporate Governance
Technology
The Science
Development
Publications
Media
News & Media
Contact
Privacy Policy
Terms & Conditions
